NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 22, 2024 $0.0930 +1.64% $0.0915 X 98.36% 0
coralli coralli Merchant
Mar 22, 2024 $0.0890 -1.22% $0.0915 X 97.27% 0
JS JS Pro
Mar 20, 2024 $0.0910 +1.00% $0.0901 X 99.00% 1
Mar 20, 2024 $0.0956 +6.09% $0.0901 X 93.91% 0
Mar 20, 2024 $0.0935 +3.80% $0.0901 X 96.20% 0
JS JS Pro
Mar 15, 2024 $0.0950 -5.19% $0.0941 V 99.04% 2
Mar 15, 2024 $0.0940 -6.21% $0.0941 V 99.87% 6
Mar 15, 2024 $0.0963 -3.88% $0.0941 V 97.65% 1
Mar 15, 2024 $0.120 +19.76% $0.0941 X 72.48% 0
JS JS Pro
Mar 14, 2024 $0.128 +4.83% $0.100 X 72.26% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE